Tuesday, May 16, 2017

BRIEF-Coherus Biosciences prevails in '135 IPR decision

* Coherus Biosciences - patent trial, appeal board of U.S. Patent And Trademark Office ruled in favor of review of Abbvie's U.S. patent 8,889,135

by reutersCOMPANYNEWS via Endless Supplies .Biz - News
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)